Estrogen receptor β gene polymorphisms and susceptibility to uterine fibroids

Gynecological Endocrinology

Volumn 26, Issue 1, 2010, Pages 4-9

  Fischer, Claudia ^a   Juhasz Boess, Ingolf ^a   Lattrich, Claus ^a   Ortmann, Olaf ^a   Treeck, Oliver ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Estrogen receptor ; Single nucleotide polymorphisms; Uterine fibroids

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE; STEROID HORMONE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERUS MYOMA;

ADULT; AGED; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR BETA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; UTERINE NEOPLASMS;

EID: 72749124467     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903159573     Document Type: Article

References (44)

1. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111:1037-1054.
2. Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol 2001;44:316-326.
3. Stewart EA. Uterine fibroids. Lancet 2001;357:293-298.
4. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589-1592.
5. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid 2005:2264-2282.
6. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004;10:207-220.
7. Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V. Estrogen receptor a and b in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 2008;90:1878-1885.
8. Benassayag C, Leroy MJ, Rigourd V, Robert B, Honore JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferre F. Estrogen receptors (ERa/ERb) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol 1999;276:E1112-E1118.
9. Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995;80:1876-1881.
10. Kovacs KA, Oszter A, Gocze PM, Kornyei JL, Szabo I. Comparative analysis of cyclin D1 and oestrogen receptor (a and b) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod 2001;7:1085-1091.
11. Wang H, Wu X, Englund K, Masironi B, Eriksson H, Sahlin L. Different expression of estrogen receptors a and b in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment. Gynecol Endocrinol 2001;15:443-452.
12. Li S, McLachlan JA. Estrogen-associated genes in uterine leiomyoma. Ann NY Acad Sci 2001;948:112-120.
13. Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol 2007; 107:42-47.
14. Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O. Effects of exon-deleted estrogen receptor b transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res Treat 2008;110:507-520.
15. Treeck O, Pfeiler G,Mitter D, Lattrich C, Piendl G, Ortmann O. Estrogen receptor {b}1 exerts antitumoral effects on SK-OV-3ovarian cancer cells. J Endocrinol 2007;193:421-433.
16. Alvarez-Millan JJ, Bocos C, Ferrin V, Lucas AR, Ruibal A, Schneider J. PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells. Oncology 2002;62:286-290.
17. Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 1999;84:350-353. (Pubitemid 29337118)
18. Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A. Cytotoxic T lymphocyte antigen- 4 promoter variants in breast cancer. Cancer Genet Cytogenet 2006;165:114-120.
19. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000;60:950-956.
20. Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 2003; 278:20490-20499.
21. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63:812-816.
22. Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Tamaki T, Mori I, Sakurai T, Kakudo K. Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. Anticancer Res 2002;22:1825-1828.
23. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-a polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril 2006;86:686-693.
24. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 2006;13: 136-144.
25. Gooden KM, Schroeder JC, North KE, Gammon MD, Hartmann KE, Taylor J, Baird DD. Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci 2007;14:117-120.
26. Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor a-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Human Reprod 2007;13:117-122.
27. Massart F, Becherini L, Gennari L, Facchini V, Genazzani AR, Brandi ML. Genotype distribution of estrogen receptor-a gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil Steril 2001;75:567-570.
28. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004;64:8891-8900. (Pubitemid 39665494)
29. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002;83:149-155.
30. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, Zillikens MC, Hofman A, van Leeuwen JP, Pols HA, et al. Estrogen receptor a gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005;153:327-334.
31. Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57-65.
32. Zofkova I, Zajickova K, Hill M. The estrogen receptor a gene determines serum androstenedione levels in postmenopausal women. Steroids 2002;67:815-819. (Pubitemid 35286560)
33. Hsieh YY, Chang CC, Tsai FJ, Tsai HD, Yeh LS, Lin CC, Tsai CH. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 2003;79:96-99.
34. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001;29:E88.
35. Iwamoto I, Fujino T, Douchi T, Nagata Y. Association of estrogen receptor a and b3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol 2003;102:506-511.
36. Malamitsi-Puchner A, Tziotis J, Evangelopoulos D, Fountas L, Vlachos G, Creatsas G, Sekeris CE, Moutsatsou P. Gene analysis of the N-terminal region of the estrogen receptor a in preeclampsia. Steroids 2001;66:695-700.
37. Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, Girao MJ, Nishimura E, Baracat EC, Silva ID. Estrogen receptor a polymorphism and susceptibility to uterine leiomyoma. Steroids 2006;71:960-965.
38. Ogawa S, Hosoi T, Shiraki M, Orimo H, Emi M, Muramatsu M, Ouchi Y, Inoue S. Association of estrogen receptor b gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000;269:537-541. (Pubitemid 30440336)
39. Rosenkranz K, Hinney A, Ziegler A, Hermann H, Fichter M, Mayer H, Siegfried W, Young JK, Remschmidt H, Hebebrand J. Systematic mutation screening of the estrogen receptor b gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 1998;83: 4524-4527.
40. Sundarrajan C, Liao WX, Roy AC, Ng SC. Association between estrogen receptor-b gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001;86:135-139.
41. Gao J, Shan G, Sun B, Thompson PJ, Gao X. Association between polymorphism of tumour necrosis factor a- 308 gene promoter andasthma: ameta-analysis.Thorax2006;61:466-471.
42. Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Rabban JT, Chen LM, Dahiya R. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.Cancer 2008;112:1964-1973.
43. Beleza-Meireles A, Kockum I, Lundberg F, Soderhall C, Nordenskjold A. Risk factors for hypospadias in the estrogen receptor 2 gene. J Clin Endocrinol Metab 2007;92:3712-3718.
44. Thellenberg-Karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-Balter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, et al. Estrogen receptor b polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006;12:1936-1941.